Grace Therapeutics Announces Second Fiscal Quarter 2025 Financial Results, Provides Business Update
| GRCE Stock | 3.66 0.30 8.93% |
About 55% of Grace Therapeutics,'s shareholders are presently thinking to get in. The analysis of overall sentiment of trading Grace Therapeutics, stock suggests that some investors are interested at this time. The current market sentiment, together with Grace Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Grace Therapeutics, stock news signals to limit their universe of possible portfolio assets.
Grace |
STRIVE-ON Data Readout Expected First Calendar Quarter 2025 NDA Submission on Track for 1H Calendar 2025 Completed Corporate Re-Branding, Connecting...
Read at globenewswire.com
 |
Grace Therapeutics, Fundamental Analysis
We analyze Grace Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Grace Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Grace Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
Grace Therapeutics, is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Grace Therapeutics, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Grace Therapeutics, stock to make a market-neutral strategy. Peer analysis of Grace Therapeutics, could also be used in its relative valuation, which is a method of valuing Grace Therapeutics, by comparing valuation metrics with similar companies.
Peers
Grace Therapeutics, Related Equities
| CRHKF | China Resources | 9.74 | ||||
| RETO | ReTo Eco | 3.41 | ||||
| IPGP | IPG Photonics | 2.20 | ||||
| TBVPY | Thai Beverage | 0.00 | ||||
| SNDL | SNDL | 1.11 | ||||
| CEIX | Consol Energy | 2.30 |
Complementary Tools for Grace Stock analysis
When running Grace Therapeutics,'s price analysis, check to measure Grace Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grace Therapeutics, is operating at the current time. Most of Grace Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Grace Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grace Therapeutics,'s price. Additionally, you may evaluate how the addition of Grace Therapeutics, to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |